Overview
Study information
Network: | CAVD |
Grant Affiliation: | NA |
Strategy: | Prophylactic neutralizing Ab |
Study Type: | Antibody Characterization |
Species: | Human |
Stage: | In progress |
Study Start Date: | NA |
Study Made Public: | NA |
Title
Cell factories for durable protein expression - A bNAb neutralization assessment
Description
CAVD 902 is a monoclonal antibody characterization study evaluating the neutralization activity of 3BNC117, PGT121, and 3BNC117 & PGT121 producing cell supernatants compared to purified monoclonal antibody standards.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.